Pathway Testing for Longitudinal Metabolomics
Overview
Affiliations
We propose a top-down approach for pathway analysis of longitudinal metabolite data. We apply a score test based on a shared latent process mixed model which can identify pathways with differentially progressing metabolites. The strength of our approach is that it can handle unbalanced designs, deals with potential missing values in the longitudinal markers, and gives valid results even with small sample sizes. Contrary to bottom-up approaches, correlations between metabolites are explicitly modeled leveraging power gains. For large pathway sizes, a computationally efficient solution is proposed based on pseudo-likelihood methodology. We demonstrate the advantages of the proposed method in identification of differentially expressed pathways through simulation studies. Finally, longitudinal metabolite data from a mice experiment is analyzed to demonstrate our methodology.
Ma G, Kang J, Yu T Brief Bioinform. 2024; 25(3).
PMID: 38581417 PMC: 10998539. DOI: 10.1093/bib/bbae141.
Multiomic characterization of disease progression in mice lacking dystrophin.
Signorelli M, Tsonaka R, Aartsma-Rus A, Spitali P PLoS One. 2023; 18(3):e0283869.
PMID: 37000843 PMC: 10065259. DOI: 10.1371/journal.pone.0283869.
Metapone: a Bioconductor package for joint pathway testing for untargeted metabolomics data.
Tian L, Li Z, Ma G, Zhang X, Tang Z, Wang S Bioinformatics. 2022; 38(14):3662-3664.
PMID: 35639952 PMC: 9272804. DOI: 10.1093/bioinformatics/btac364.
Signorelli M, Spitali P, Szigyarto C, Tsonaka R Stat Med. 2021; 40(27):6178-6196.
PMID: 34464990 PMC: 9293191. DOI: 10.1002/sim.9178.
Pathway testing for longitudinal metabolomics.
Ebrahimpoor M, Spitali P, Goeman J, Tsonaka R Stat Med. 2021; 40(13):3053-3065.
PMID: 33768548 PMC: 8252476. DOI: 10.1002/sim.8957.